| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 80, 2752-2755, Copyright © 1995 by Endocrine Society
ARTICLES |
A Falorni, A Nikoshkov, S Laureti, E Grenback, AL Hulting, G Casucci, F Santeusanio, P Brunetti, H Luthman and A Lernmark
Department of Molecular Medicine, Karolinska Institute, Stockholm, Sweden.
Autoantibodies against 21-hydroxylase (P450c21) are common in idiopathic autoimmune Addison's disease. In the present work, we have developed a sensitive radiobinding assay using in vitro translated recombinant human 35S-P450c21. Levels of P450c21 antibodies (P450c21- Ab) were expressed as a relative index (P450c21 index) using a P450c21- Ab positive Addisonian serum and two antibody-negative healthy sera as positive and negative standards in healthy individuals. The upper level of normal was the mean + 3 SD. Positivity for P450c21-Ab was confirmed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis of immunoprecipitated 35S-P450c21. In 38 Addisonian patients, P450c21-Ab were found in 24/28 (86%) idiopathic, 0/5 post-tuberculosis, 0/3 adrenoleukodystrophy, and 0/2 post-adrenalectomy sera. Among healthy individuals, 1/70 (1.4%) were positive. The P450c21 index, as an estimate of P450c21-Ab levels, correlated inversely with the duration of idiopathic Addison's disease (r = -0.527; P = 0.007): 16/16 (100%) positive in patients with less than 20 yr and 8/12 (67%) positive in patients with more than 20 yr disease duration. The availability of this simple and sensitive radiobinding assay to evaluate levels of P450c21-Ab will permit large clinical studies as well as screening subjects at risk. In addition, the general population can now be screened to evaluate the predictive value of P450c21-Ab for Addison's disease.
This article has been cited by other articles:
![]() |
A. Tsigkou, S. Marzotti, L. Borges, A. Brozzetti, F. Reis, P. Candeloro, M. Luisa Bacosi, V. Bini, F. Petraglia, and A. Falorni High Serum Inhibin Concentration Discriminates Autoimmune Oophoritis from Other Forms of Primary Ovarian Insufficiency J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1263 - 1269. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z Gombos, R Hermann, M Kiviniemi, S Nejentsev, K Reimand, V Fadeyev, P Peterson, R Uibo, and J Ilonen Analysis of extended human leukocyte antigen haplotype association with Addison's disease in three populations Eur. J. Endocrinol., December 1, 2007; 157(6): 757 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Candeloro, C. B. Voltattorni, R. Perniola, M. Bertoldi, C. Betterle, M. Mannelli, R. Giordano, A. De Bellis, C. Tiberti, S. Laureti, et al. Mapping of Human Autoantibody Epitopes on Aromatic L-Amino Acid Decarboxylase J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1096 - 1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Husebye, E. Bratland, G. Bredholt, M. Fridkin, M. Dayan, and E. Mozes The Substrate-Binding Domain of 21-Hydroxylase, the Main Autoantigen in Autoimmune Addison's Disease, Is an Immunodominant T Cell Epitope Endocrinology, May 1, 2006; 147(5): 2411 - 2416. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Welt, A. Falorni, A. E. Taylor, K. A. Martin, and J. E. Hall Selective Theca Cell Dysfunction in Autoimmune Oophoritis Results in Multifollicular Development, Decreased Estradiol, and Elevated Inhibin B Levels J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3069 - 3076. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Barker, J. Yu, L. Yu, J. Wang, D. Miao, F. Bao, E. Hoffenberg, J. C. Nelson, P. A. Gottlieb, M. Rewers, et al. Autoantibody "Subspecificity" in Type 1 Diabetes: Risk for organ-specific autoimmunity clusters in distinct groups Diabetes Care, April 1, 2005; 28(4): 850 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Barker, A. Ide, C. Hostetler, L. Yu, D. Miao, P. R. Fain, G. S. Eisenbarth, and P. A. Gottlieb Endocrine and Immunogenetic Testing in Individuals with Type 1 Diabetes and 21-Hydroxylase Autoantibodies: Addison's Disease in a High-Risk Population J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 128 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Falorni, S. Laureti, A. De Bellis, R. Zanchetta, C. Tiberti, G. Arnaldi, V. Bini, P. Beck-Peccoz, A. Bizzarro, F. Dotta, et al. Italian Addison Network Study: Update of Diagnostic Criteria for the Etiological Classification of Primary Adrenal Insufficiency J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1598 - 1604. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Soderbergh, A. G. Myhre, O. Ekwall, G. Gebre-Medhin, H. Hedstrand, E. Landgren, A. Miettinen, P. Eskelin, M. Halonen, T. Tuomi, et al. Prevalence and Clinical Associations of 10 Defined Autoantibodies in Autoimmune Polyendocrine Syndrome Type I J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 557 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Betterle, C. Dal Pra, F. Mantero, and R. Zanchetta Autoimmune Adrenal Insufficiency and Autoimmune Polyendocrine Syndromes: Autoantibodies, Autoantigens, and Their Applicability in Diagnosis and Disease Prediction Endocr. Rev., June 1, 2002; 23(3): 327 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. BALAJI, A. SHTAUVERE-BRAMEUS, V. BALAJI, V. SESHIAH, and C. B. SANJEEVI Women Diagnosed with Gestational Diabetes Mellitus Do Not Carry Antibodies against Minor Islet Cell Antigens Ann. N.Y. Acad. Sci., April 1, 2002; 958(1): 281 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Myhre, D. E. Undlien, K. Lovas, S. Uhlving, B. G. Nedrebo, K. J. Fougner, T. Trovik, J. I. Sorheim, and E. S. Husebye Autoimmune Adrenocortical Failure in Norway Autoantibodies and Human Leukocyte Antigen Class II Associations Related to Clinical Features J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 618 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Yamamoto, P. Gajdos, B. Eymard, C. Tranchant, J.-M. Warter, L. Gomez, C. Bourquin, J.-F. Bach, and H.-J. Garchon Anti-Titin Antibodies in Myasthenia Gravis: Tight Association With Thymoma and Heterogeneity of Nonthymoma Patients Arch Neurol, June 1, 2001; 58(6): 885 - 890. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Wesche, E Jaeckel, C Trautwein, H Wedemeyer, A Falorni, H Frank, A von zur Muhlen, M-P Manns, and G Brabant Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C Gut, March 1, 2001; 48(3): 378 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. De Bellis, A. Falorni, S. Laureti, S. Perrino, C. Coronella, F. Forini, E. Bizzarro, A. Bizzarro, G. Abbate, and A. Bellastella Time Course of 21-Hydroxylase Antibodies and Long-Term Remission of Subclinical Autoimmune Adrenalitis after Corticosteroid Therapy: Case Report J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 675 - 678. [Abstract] [Full Text] |
||||
![]() |
J. Seissler, S. Wagner, M. Schott, M. Lettmann, J. Feldkamp, W. A. Scherbaum, and N. G. Morgenthaler Low Frequency of Autoantibodies to the Human Na+/I- Symporter in Patients with Autoimmune Thyroid Disease J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4630 - 4634. [Abstract] [Full Text] |
||||
![]() |
G. Gambelunghe, A. Falorni, M. Ghaderi, S. Laureti, C. Tortoioli, F. Santeusanio, P. Brunetti, and C. B. Sanjeevi Microsatellite Polymorphism of the MHC Class I Chain-Related (MIC-A and MIC-B) Genes Marks the Risk for Autoimmune Addison's Disease J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3701 - 3707. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nikoshkov, A. Falorni, S. Lajic, S. Laureti, A. Wedell, A. Lernmark, and H. Luthman A Conformation-Dependent Epitope in Addison's Disease and Other Endocrinological Autoimmune Diseases Maps to a Carboxyl-Terminal Functional Domain of Human Steroid 21-Hydroxylase J. Immunol., February 15, 1999; 162(4): 2422 - 2426. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Betterle, M. Volpato, B. Pedini, S. Chen, B. Rees Smith, and J. Furmaniak Adrenal-Cortex Autoantibodies and Steroid-Producing Cells Autoantibodies in Patients with Addison's Disease: Comparison of Immunofluorescence and Immunoprecipitation Assays J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 618 - 622. [Abstract] [Full Text] |
||||
![]() |
L. Yu, K. W. Brewer, S. Gates, A. Wu, T. Wang, S. R. Babu, P. A. Gottlieb, B. M. Freed, J. Noble, H. A. Erlich, et al. DRB104 and DQ Alleles: Expression of 21-Hydroxylase Autoantibodies and Risk of Progression to Addison's Disease J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 328 - 335. [Abstract] [Full Text] |
||||
![]() |
S. Laureti, A. De Bellis, V. I. Muccitelli, F. Calcinaro, A. Bizzarro, R. Rossi, A. Bellastella, F. Santeusanio, and A. Falorni Levels of Adrenocortical Autoantibodies Correlate with the Degree of Adrenal Dysfunction in Subjects with Preclinical Addison's Disease J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3507 - 3511. [Abstract] [Full Text] |
||||
![]() |
S. Laureti, P. Aubourg, F. Calcinaro, F. Rocchiccioli, G. Casucci, G. Angeletti, P. Brunetti, A. Lernmark, F. Santeusanio, and A. Falorni Etiological Diagnosis of Primary Adrenal Insufficiency Using an Original Flowchart of Immune and Biochemical Markers J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3163 - 3168. [Abstract] [Full Text] |
||||
![]() |
S. Chen, J. Sawicka, L. Prentice, J. F. Sanders, H. Tanaka, V. Petersen, C. Betterle, M. Volpato, S. Roberts, M. Powell, et al. Analysis of Autoantibody Epitopes on Steroid 21-Hydroxylase Using a Panel of Monoclonal Antibodies J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2977 - 2986. [Abstract] [Full Text] |
||||
![]() |
K. W. Brewer, V. S. Parziale, and G. S. Eisenbarth Screening Patients with Insulin-Dependent Diabetes Mellitus for Adrenal Insufficiency N. Engl. J. Med., July 17, 1997; 337(3): 202 - 202. [Full Text] |
||||
![]() |
H. Tanaka, M. S. Perez, M. Powell, J. F. Sanders, J. Sawicka, S. Chen, L. Prentice, T. Asawa, C. Betterle, M. Volpato, et al. Steroid 21-Hydroxylase Autoantibodies: Measurements with a New Immunoprecipitation Assay J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1440 - 1446. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Husebye, G. Gebre-Medhin, T. Tuomi, J. Perheentupa, M. Landin-Olsson, J. Gustafsson, F. Rorsman, and O. Kampe Autoantibodies against Aromatic L-Amino Acid Decarboxylase in Autoimmune Polyendocrine Syndrome Type I J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 147 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Oelkers Adrenal Insufficiency N. Engl. J. Med., October 17, 1996; 335(16): 1206 - 1212. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |